Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro.

Author: LiChunlai, LiangBeiwei, XieYubo, ZhouZhan

Paper Details 
Original Abstract of the Article :
Experimental data indicate that morphine and fentanyl may have antitumor effects in gastric cancer cells (GC). Hydromorphone, as an analgesic, is used against refractory cancer pain in recent years. However, the data on hydromorphone influencing the biological characteristics of human gastric cancer...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086391/

データ提供:米国国立医学図書館(NLM)

Hydromorphone: A Potential Oasis in the Desert of Gastric Cancer

The fight against gastric cancer is a challenging journey, with researchers constantly seeking new and effective treatments. This study investigates the potential antitumor effects of hydromorphone, an opioid analgesic commonly used for refractory cancer pain, on human gastric cancer cells in vitro. The authors explore the impact of hydromorphone on the growth and biological characteristics of gastric cancer cells.

Hydromorphone: A Potential Oasis in the Desert of Gastric Cancer

The study's findings suggest that hydromorphone may have antitumor effects on human gastric cancer cells. The authors demonstrate that hydromorphone can inhibit the growth of gastric cancer cells in vitro. This finding is encouraging, as it suggests a potential therapeutic role for hydromorphone, a medication already used for pain management, in combating gastric cancer.

Hydromorphone: A Potential Oasis in the Desert of Gastric Cancer

This research opens a new avenue for exploring the potential of existing medications, such as hydromorphone, in treating gastric cancer. The study's findings encourage further research into the mechanisms of action of hydromorphone and its potential as a therapeutic agent for gastric cancer. This research could contribute to the development of innovative and multi-faceted treatment strategies for this challenging disease.

Dr. Camel's Conclusion

The desert of gastric cancer can be a harsh and unforgiving landscape, but this study suggests that hydromorphone may offer a potential oasis in the search for new treatments. While more research is needed to confirm these findings, the study's results provide a glimmer of hope for individuals battling this challenging disease.

Date :
  1. Date Completed 2023-04-17
  2. Date Revised 2023-04-17
Further Info :

Pubmed ID

37057060

DOI: Digital Object Identifier

PMC10086391

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.